ROMIPLOSTIM AND ELTROMBOPAG FOR IMMUNE THROMBOCYTOPENIA: METHODS FOR INDIRECT COMPARISON
نویسندگان
چکیده
منابع مشابه
Romiplostim and eltrombopag for immune thrombocytopenia: methods for indirect comparison.
OBJECTIVES Immune thrombocytopenia (ITP) causes increased platelet destruction and suboptimal platelet production, increasing risk of bleeding. This analysis uses a Bayesian metaregression model to indirectly compare effectiveness of the thrombopoietin mimetics romiplostim and eltrombopag for increasing platelet counts, and contrasts the results with those of non-Bayesian approaches. METHODS ...
متن کاملUpdate on romiplostim and eltrombopag indirect comparison.
1. Husereau D, DrummondM, Petrou S, et al. Consolidated health economic evaluation reporting standards (CHEERS) statement. Int J Technol Assess in Health Care. 2013;29:117-122. 2. Bell CM, Urbach DR, Ray JG, et al. Bias in published cost-effectiveness studies: Systematic review. BMJ. 2006;332:699-703. 3. Peura PK, Martikainen JA, Purmonen TT, Turunen JH. Sponsorshiprelated outcome selection bia...
متن کاملEltrombopag for the treatment of chronic immune thrombocytopenia
ISSN 2041-6792 10.4155/CLI.10.23 © 2011 Future Science Ltd Immune thrombocytopenic purpura (ITP) is an immune-mediated platelet disorder. Although early studies suggest that the main feature is antiplatelet antibody production and increased platelet clearance, more recent evidence implies that defective platelet production and suppressed maturation and differentiation of megakaryocytes also occ...
متن کاملRemissions after long-term use of romiplostim for immune thrombocytopenia.
Immune thrombocytopenia (ITP) is an acquired autoimmune condition whereby autoantibodies against platelets lead to increased platelet clearance, suppression of megakaryocytopoiesis, and subsequent thrombocytopenia. ITP is associated with increased bleeding risk, and the primary goal of therapy is to prevent clinically significant bleeding. Steroids, and in some cases intravenous immunoglobulin,...
متن کاملRomiplostim as a treatment for immune thrombocytopenia: a review
"Immune thrombocytopenia" (ITP) is an autoimmune disorder that leads to peripheral destruction, as well as a decreased production of platelets. ITP most commonly presents as mild mucocutaneous bleeding. Though it is rare, the leading cause of mortality in persons with ITP is intracranial hemorrhage and those that do not respond to therapy are at increased risk. Our understanding of the pathophy...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: International Journal of Technology Assessment in Health Care
سال: 2012
ISSN: 0266-4623,1471-6348
DOI: 10.1017/s0266462312000414